Trials / Conditions / Phase 2
Phase 2
3 registered clinical trials studyying Phase 2 — 3 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | Phase 2 Trial Of Sacituzumab Tirumotecan For Treatment Of Refractory Metastatic Or Unresectable Squamous Cell NCT07511023 | M.D. Anderson Cancer Center | Phase 2 |
| Recruiting | Phase 2 Trial of Zanzalintinib and Pembrolizumab in Select Subtypes of Advanced/Metastatic Soft-tissue Sarcoma NCT07283731 | M.D. Anderson Cancer Center | Phase 2 |
| Recruiting | A Phase 2 Study of Radiotherapy-induced Immune Priming to Enhance Elranatamab (Elra) in Relapsed Refractory Mu NCT07382739 | M.D. Anderson Cancer Center | Phase 2 |